Further evidence for Clockδ19 mice as a model for bipolar disorder mania using cross-species tests of exploration and sensorimotor gating

Behavioural Brain Research

Volumn 249, Issue , 2013, Pages 44-54

  van Enkhuizen, Jordy ^a,b   Minassian, Arpi ^a,c   Young, Jared W ^a,d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UTRECHT UNIVERSITY   (Netherlands)

^c Veteran's Administration   (United States)

^d VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

Author keywords

Bipolar disorder; Circadian; Clock; Cycling; Hedonia; Mania; PPI

Indexed keywords

TRANSCRIPTION FACTOR CLOCK;

ANHEDONIA; ANIMAL BEHAVIOR; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIPOLAR DISORDER; CIRCADIAN RHYTHM; CONTROLLED STUDY; EXPLORATORY BEHAVIOR; FEMALE; GENOTYPE; HABITUATION; HYPERACTIVITY; LOCOMOTION; MALE; MANIA; MOUSE; NONHUMAN; PHOTOPERIODICITY; PRIORITY JOURNAL; SENSORY GATING; SPECIES DIFFERENCE; STARTLE REFLEX; TRANSCRIPTION INITIATION;

ANIMALS; BEHAVIOR, ANIMAL; BIPOLAR DISORDER; CIRCADIAN RHYTHM; CLOCK PROTEINS; DISEASE MODELS, ANIMAL; EXPLORATORY BEHAVIOR; FEMALE; MALE; MICE; MICE, TRANSGENIC; MOTOR ACTIVITY; SENSORY GATING; STARTLE REACTION;

EID: 84877792484     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2013.04.023     Document Type: Article

References (78)

1. Kessler R.C., Demler O., Frank R.G., Olfson M., Pincus H.A., Walters E.E., et al. Prevalence and treatment of mental disorders, 1990 to 2003. New England Journal of Medicine 2005, 352:2515-2523.
2. Gould T.D., Einat H. Animal models of bipolar disorder and mood stabilizer efficacy: a critical need for improvement. Neuroscience and Biobehavioral Reviews 2007, 31:825-831.
3. Young J.W., Henry B.L., Geyer M.A. Predictive animal models of mania, hits, misses, and future directions. British Journal of Pharmacology 2011.
4. Malkesman O., Austin D.R., Chen G., Manji H.K. Reverse translational strategies for developing animal models of bipolar disorder. Disease Models & Mechanisms 2009, 2:238-245.
5. Belmaker R.H., Bersudsky Y. Bipolar disorder: mania and depression. Discovery Medicine 2004, 4:239-245.
6. Diagnostic A.P.A. Statistical manual of mental disorders 1994, American Psychiatric Association, Washington, DC. 4th ed.
7. Cassidy F., Carroll B.J. Seasonal variation of mixed and pure episodes of bipolar disorder. Journal of Affective Disorders 2002, 68:25-31.
8. Friedman E., Gyulai L., Bhargava M., Landen M., Wisniewski S., Foris J., et al. Seasonal changes in clinical status in bipolar disorder: a prospective study in 1000 STEP-BD patients. Acta Psychiatrica Scandinavica 2006, 113:510-517.
9. Sherman J.A. Evolutionary origin of bipolar disorder-revised: EOBD-R. Medical Hypotheses 2012, 78:113-122.
10. Ko C.H., Takahashi J.S. Molecular components of the mammalian circadian clock. Human Molecular Genetics 2006, 2:15. Spec No. R271-277.
11. McClung C.A. Role for the Clock gene in bipolar disorder. Cold Spring Harbor Symposia on Quantitative Biology 2007, 72:637-644.
12. McClung C.R. The photomorphogenic protein DE-ETIOLATED 1, is a critical transcriptional corepressor in the central loop of the Arabidopsis circadian clock. Molecular Cell 2011, 43:693-694.
13. Terman M., Terman J.S. Light therapy for seasonal and nonseasonal depression: efficacy, protocol, safety, and side effects. CNS Spectrums 2005, 10:647-663. quiz 72.
14. Sitaram N., Gillin J.C., Bunney W.E. The switch process in manic-depressive illness Circadian variation in time of switch and sleep and manic ratings before and after switch. Acta Psychiatrica Scandinavica 1978, 58:267-278.
15. Frank E., Swartz H.A., Kupfer D.J. Interpersonal and social rhythm therapy: managing the chaos of bipolar disorder. Biological Psychiatry 2000, 48:593-604.
16. Wehr T.A., Turner E.H., Shimada J.M., Lowe C.H., Barker C., Leibenluft E. Treatment of rapidly cycling bipolar patient by using extended bed rest and darkness to stabilize the timing and duration of sleep. Biological Psychiatry 1998, 43:822-828.
17. Bunney B.G., Bunney W.E. Mechanisms of rapid antidepressant effects of sleep deprivation therapy: Clock genes and Circadian rhythms. Biological Psychiatry 2012.
18. Salvadore G., Quiroz J.A., Machado-Vieira R., Henter I.D., Manji H.K., Zarate C.A. The neurobiology of the switch process in bipolar disorder: a review. Journal of Clinical Psychiatry 2010, 71:1488-1501.
19. Roybal K., Theobold D., Graham A., DiNieri J.A., Russo S.J., Krishnan V., et al. Mania-like behavior induced by disruption of CLOCK. Proceedings of the National Academy of Sciences of the United States of America 2007, 104:6406-6411.
20. McClung C.A., Sidiropoulou K., Vitaterna M., Takahashi J.S., White F.J., Cooper D.C., et al. Regulation of dopaminergic transmission and cocaine reward by the Clock gene. Proceedings of the National Academy of Sciences of the United States of America 2005, 102:9377-9381.
21. Coque L., Mukherjee S., Cao J.L., Spencer S., Marvin M., Falcon E., et al. Specific role of VTA dopamine neuronal firing rates and morphology in the reversal of anxiety-related, but not depression-related behavior in the ClockDelta19 mouse model of mania. Neuropsychopharmacology 2011, 36:1478-1488.
22. Benedetti F., Serretti A., Colombo C., Barbini B., Lorenzi C., Campori E., et al. Influence of CLOCK gene polymorphism on circadian mood fluctuation and illness recurrence in bipolar depression. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 2003, 123B::23-26.
23. Serretti A., Benedetti F., Mandelli L., Lorenzi C., Pirovano A., Colombo C., et al. Genetic dissection of psychopathological symptoms: insomnia in mood disorders and CLOCK gene polymorphism. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 2003, 121B:35-38.
24. Henry B.L., Minassian A., Young J.W., Paulus M.P., Geyer M.A., Perry W. Cross-species assessments of motor and exploratory behavior related to bipolar disorder. Neuroscience and Biobehavioral Reviews 2010, 34:1296-1306.
25. Minassian A., Henry B.L., Geyer M.A., Paulus M.P., Young J.W., Perry W. The quantitative assessment of motor activity in mania and schizophrenia. Journal of Affective Disorders 2009, 120:200-206.
26. Perry W., Minassian A., Henry B., Kincaid M., Young J.W., Geyer M.A. Quantifying over-activity in bipolar and schizophrenia patients in a human open field paradigm. Psychiatry Research 2010, 178:84-91.
27. Young J.W., Minassian A., Paulus M.P., Geyer M.A., Perry W. A reverse-translational approach to bipolar disorder: rodent and human studies in the Behavioral Pattern Monitor. Neuroscience and Biobehavioral Reviews 2007, 31:882-896.
28. Perry W., Minassian A., Paulus M.P., Young J.W., Kincaid M.J., Ferguson E.J., et al. A reverse-translational study of dysfunctional exploration in psychiatric disorders: from mice to men. Archives of General Psychiatry 2009, 66:1072-1080.
29. Minassian A., Henry B.L., Young J.W., Masten V., Geyer M.A., Perry W. Repeated assessment of exploration and novelty seeking in the human behavioral pattern monitor in bipolar disorder patients and healthy individuals. PLoS One 2011, 6:e24185.
30. van Enkhuizen J., Geyer M.A., Kooistra K., Young J.W. Chronic valproate attenuates some, but not all, facets of mania-like behaviour in mice. International Journal of Neuropsychopharmacology 2012, 1-11.
31. Young J.W., Goey A.K., Minassian A., Perry W., Paulus M.P., Geyer M.A. GBR 12909 administration as a mouse model of bipolar disorder mania: mimicking quantitative assessment of manic behavior. Psychopharmacology 2010, 208:443-454.
32. Young J.W., Goey A.K., Minassian A., Perry W., Paulus M.P., Geyer M.A. The mania-like exploratory profile in genetic dopamine transporter mouse models is diminished in a familiar environment and reinstated by subthreshold psychostimulant administration. Pharmacology Biochemistry and Behavior 2010, 96:7-15.
33. Young J.W., Kooistra K., Geyer M.A. Dopamine receptor mediation of the exploratory/hyperactivity effects of modafinil. Neuropsychopharmacology 2011, 36:1385-1396.
34. Perry W., Minassian A., Feifel D., Braff D.L. Sensorimotor gating deficits in bipolar disorder patients with acute psychotic mania. Biological Psychiatry 2001, 50:418-424.
35. Geyer M.A., McIlwain K.L., Paylor R. Mouse genetic models for prepulse inhibition: an early review. Molecular Psychiatry 2002, 7:1039-1053.
36. Geyer M.A., Swerdlow N.R. Measurement of startle response, prepulse inhibition, and habituation. Curr Protoc Neurosci 2001, Chapter 8:Unit 8.7.
37. Powell S.B., Young J.W., Ong J.C., Caron M.G., Geyer M.A. Atypical antipsychotics clozapine and quetiapine attenuate prepulse inhibition deficits in dopamine transporter knockout mice. Behavioural Pharmacology 2008, 19:562-565.
38. Powell S.B., Zhou X., Geyer M.A. Prepulse inhibition and genetic mouse models of schizophrenia. Behavioural Brain Research 2009, 204:282-294.
39. Flaisher-Grinberg S., Overgaard S., Einat H. Attenuation of high sweet solution preference by mood stabilizers: a possible mouse model for the increased reward-seeking domain of mania. Journal of Neuroscience Methods 2009, 177:44-50.
40. King D.P., Zhao Y., Sangoram A.M., Wilsbacher L.D., Tanaka M., Antoch M.P., et al. Positional cloning of the mouse circadian clock gene. Cell 1997, 89:641-653.
41. Halberstadt A.L., van der Heijden I., Ruderman M.A., Risbrough V.B., Gingrich J.A., Geyer M.A., et al. 5-HT(2A) and 5-HT(2C) receptors exert opposing effects on locomotor activity in mice. Neuropsychopharmacology 2009, 34:1958-1967.
42. Risbrough V.B., Masten V.L., Caldwell S., Paulus M.P., Low M.J., Geyer M.A. Differential contributions of dopamine D(1) D(2), and D(3) receptors to MDMA-induced effects on locomotor behavior patterns in mice. Neuropsychopharmacology 2006, 31:2349-2358.
43. Tanaka S., Young J.W., Halberstadt A.L., Masten V.L., Geyer M.A. Four factors underlying mouse behavior in an open field. Behavioural Brain Research 2012, 233:55-61.
44. Geyer M.A., Russo P.V., Masten V.L. Multivariate assessment of locomotor behavior: pharmacological and behavioral analyses. Pharmacology Biochemistry and Behavior 1986, 25:277-288.
45. Paulus M.P., Geyer M.A. A temporal and spatial scaling hypothesis for the behavioral effects of psychostimulants. Psychopharmacology 1991, 104:6-16.
46. Young J.W., Meves J.M., Tarantino I.S., Caldwell S., Geyer M.A. Delayed procedural learning in alpha7-nicotinic acetylcholine receptor knockout mice. Genes, Brain & Behavior 2011, 10:720-733.
47. Paulus M.P., Callaway C.W., Geyer M.A. Quantitative assessment of the microstructure of rat behavior: II Distinctive effects of dopamine releasers and uptake inhibitors. Psychopharmacology 1993, 113:187-198.
48. Young J.W., Wallace C.K., Geyer M.A., Risbrough V.B. Age-associated improvements in cross-modal prepulse inhibition in mice. Behavioral Neuroscience 2010, 124:133-140.
49. van Enkhuizen J., Geyer M.A., Young J.W. Differential effects of dopamine transporter inhibitors in the rodent Iowa gambling task: relevance to mania. Psychopharmacology 2013, 225:661-674.
50. Young J.W., van Enkhuizen J., Winstanley C.A., Geyer M.A. Increased risk-taking behavior in dopamine transporter knockdown mice: further support for a mouse model of mania. J Psychopharmacol 2011, 25:934-943.
51. Zhuang X., Oosting R.S., Jones S.R., Gainetdinov R.R., Miller G.W., Caron M.G., et al. Hyperactivity and impaired response habituation in hyperdopaminergic mice. Proceedings of the National Academy of Sciences of the United States of America 2001, 98:1982-1987.
52. Cappeliez P., Moore E. Effects of lithium on an amphetamine animal model of bipolar disorder. Progress in Neuro-Psychopharmacology and Biological Psychiatry 1990, 14:347-358.
53. Frey B.N., Valvassori S.S., Reus G.Z., Martins M.R., Petronilho F.C., Bardini K., et al. Effects of lithium and valproate on amphetamine-induced oxidative stress generation in an animal model of mania. Journal of Psychiatry and Neuroscience 2006, 31:326-332.
54. Gould T.J., Keith R.A., Bhat R.V. Differential sensitivity to lithium's reversal of amphetamine-induced open-field activity in two inbred strains of mice. Behavioural Brain Research 2001, 118:95-105.
55. Braff D., Stone C., Callaway E., Geyer M., Glick I., Bali L. Prestimulus effects on human startle reflex in normals and schizophrenics. Psychophysiology 1978, 15:339-343.
56. Braff D.L., Geyer M.A. Sensorimotor gating and schizophrenia. Human and animal model studies. Archives of General Psychiatry 1990, 47:181-188.
57. Young J., Kamenski M., Geyer M. Delayed 'eureka' of alpha 7 nicotinic acetylcholine receptor knockout mice in a probabilistic reversal learning paradigm. Schizophrenia Research 2012, 136:S361.
58. Swerdlow N.R., Eastvold A., Uyan K.M., Ploum Y., Cadenhead K. Matching strategies for drug studies of prepulse inhibition in humans. Behavioural Pharmacology 2001, 12:45-52.
59. Schurhoff F., Szoke A., Bellivier F., Turcas C., Villemur M., Tignol J., et al. Anhedonia in schizophrenia: a distinct familial subtype?. Schizophrenia Research 2003, 61:59-66.
60. Vitaterna M.H., Ko C.H., Chang A.M., Buhr E.D., Fruechte E.M., Schook A., et al. The mouse Clock mutation reduces circadian pacemaker amplitude and enhances efficacy of resetting stimuli and phase-response curve amplitude. Proceedings of the National Academy of Sciences of the United States of America 2006, 103:9327-9332.
61. Fonken L.K., Finy M.S., Walton J.C., Weil Z.M., Workman J.L., Ross J., et al. Influence of light at night on murine anxiety- and depressive-like responses. Behavioural Brain Research 2009, 205:349-354.
62. LeGates T.A., Altimus C.M., Wang H., Lee H.K., Yang S., Zhao H., et al. Aberrant light directly impairs mood and learning through melanopsin-expressing neurons. Nature 2012, 491:594-598.
63. Mukherjee S., Coque L., Cao J.L., Kumar J., Chakravarty S., Asaithamby A., et al. Knockdown of Clock in the ventral tegmental area through RNA interference results in a mixed state of mania and depression-like behavior. Biological Psychiatry 2010, 68:503-511.
64. Spencer S., Torres-Altoro M.I., Falcon E., Arey R., Marvin M., Goldberg M., et al. A mutation in CLOCK leads to altered dopamine receptor function. Journal of Neurochemistry 2012, 123:124-134.
65. Glimcher P.W. Understanding dopamine and reinforcement learning: the dopamine reward prediction error hypothesis. Proceedings of the National Academy of Sciences of the United States of America 2011, 108(Suppl. 3):15647-15654.
66. Schultz W. Getting formal with dopamine and reward. Neuron 2002, 36:241-263.
67. Ragland J.D., Cools R., Frank M., Pizzagalli D.A., Preston A., Ranganath C., et al. CNTRICS final task selection: long-term memory. Schizophrenia Bulletin 2009, 35:197-212.
68. Goodwin G.M., Martinez-Aran A., Glahn D.C., Vieta E. Cognitive impairment in bipolar disorder: neurodevelopment or neurodegeneration? An ECNP expert meeting report. European Neuropsychopharmacology 2008, 18:787-793.
69. Burdick K.E., Braga R.J., Goldberg J.F., Malhotra A.K. Cognitive dysfunction in bipolar disorder: future place of pharmacotherapy. CNS Drugs 2007, 21:971-981.
70. Han G., Klimes-Dougan B., Jepsen S., Ballard K., Nelson M., Houri A., et al. Selective neurocognitive impairments in adolescents with major depressive disorder. Journal of Adolescence 2012, 35:11-20.
71. Linke J., Sonnekes C., Wessa M. Sensitivity to positive and negative feedback in euthymic patients with bipolar I disorder: the last episode makes the difference. Bipolar Disorders 2011, 13:638-650.
72. Bechara A., Damasio A.R., Damasio H., Anderson S.W. Insensitivity to future consequences following damage to human prefrontal cortex. Cognition 1994, 50:7-15.
73. Harms L.R., Turner K.M., Eyles D.W., Young J.W., McGrath J.J., Burne T.H. Attentional processing in C57BL/6J mice exposed to developmental vitamin D deficiency. PLoS One 2012, 7:e35896.
74. Young J.W., Powell S.B., Scott C.N., Zhou X., Geyer M.A. The effect of reduced dopamine D4 receptor expression in the 5-choice continuous performance task: Separating response inhibition from premature responding. Behavioural Brain Research 2011, 222:183-192.
75. Levin E.D., Petro A., Rezvani A.H., Pollard N., Christopher N.C., Strauss M., et al. Nicotinic alpha7- or beta2-containing receptor knockout: effects on radial-arm maze learning and long-term nicotine consumption in mice. Behavioural Brain Research 2009, 196:207-213.
76. Tarantino I.S., Sharp R.F., Geyer M.A., Meves J.M., Young J.W. Working memory span capacity improved by a D2 but not D1 receptor family agonist. Behavioural Brain Research 2011, 219:181-188.
77. Green M.F. Cognitive impairment and functional outcome in schizophrenia and bipolar disorder. Journal of Clinical Psychiatry 2006, 67(Suppl. 9):3-8. discussion 36-42.
78. Torres I.J., Defreitas C.M., Defreitas V.G., Bond D.J., Kunz M., Honer W.G., et al. Relationship between cognitive functioning and 6-month clinical and functional outcome in patients with first manic episode bipolar I disorder. Psychological Medicine 2010, 1-12.